Investigation of the Naída CI M90 Sound Processor in Various Acoustic Scenarios
- Disease/Condition
- Cochlear Hearing Loss
- Drug/Device/Intervention
- Naída CI M90 Sound Processor (hearing aid and cochlea implant sound processor)
- Study type
- Interventional
- Intervention type
- device
- Primary sponsor
- Advanced Bionics AG
- Location
- Hannover, Germany
- Phase
- N/A
- Start date
- Nov 20, 2020
- End date
- Aug 09, 2021
- Enrollment
- 20 participants
Difference in speech perception in noise with AutoSense OS on Naída M hearing devices and AutoSound OS on the clinically available Naída Q hearing devices
In this clinical trial, an un-controlled, repeated measures open design with within-subject
 comparison will be used to evaluate the effect of Naída Link M90 hearing aid and Naída CI M90
 sound processor on sound perception. This design was shown to be successful in previous
 studies for the evaluation of sound coding strategies. Furthermore, a within-subject
 comparison decreases the variance in the results allowing for fewer subjects when the
 population that uses the investigational device is not large in general.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT04815343
- Type
- Device Trial
Access comprehensive clinical trial information for NCT04815343 through Pure Global AI's free database. This phase not specified trial is sponsored by Advanced Bionics AG and is currently Completed. The study focuses on Cochlear Hearing Loss. Target enrollment is 20 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.